PWH Involvement in Case Conferencing
Resource updated 08/17/2023
Resource updated 08/17/2023
Resource updated 10/18/2023
The RUSH intervention facilitates linkage to and retention in care through an opt-out HIV te
Resource updated 09/14/2023
UCLA Family AIDS Network, a Ryan White Part D recipient, will present its new Women and HIV bilingual education video series covering the topics of mental health and pregnancy. The videos are an educational tool and innovative way organizations can encourage authentic, genuine, and holistic conversations between consumers and providers.
Resource (Conference Presentation) updated 09/14/2023
Learn about best practices for improving the quality of oral healthcare from a tested delivery model at Grady Health System. A presentation on HAB's performance measures for oral health and the utilization of data to improve care will also be shared.
Resource (Conference Presentation) updated 09/14/2023
Adoptive parents of children living with HIV will discuss issues that impact their lives in conjunction with findings from a study on adoptive parents’ experiences. The panelists will explore the differences in their parenting decisions and advise clinicians on practical ways they can support families in navigating these personal choices.
Resource (Conference Presentation) updated 09/14/2023
In a multi-site community health center system, the most challenging patients with HIV and hepatitis C (HCV) co-infection were assessed for HICV cure, and the solutions developed to overcome their barriers to treatment were translated into systems change. The presenters will discuss the challenges, solutions, and resultant system changes.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Establishing an opt-out HIV screening program in the emergency department has almost quadrupled HIV screening rates and has identified new and out-of-care cases. Utilizing a continuous quality improvement approach has allowed it to become a catalyst to improve workflows for other gaps in University Medical Center of Southern Nevada's HIV care continuum process.
Resource (Conference Presentation) updated 09/14/2023
Learn how to develop, plan, and implement an organization-wide ECHO model to fully integrate HIV/HCV care and treatment into primary care centers and create wider access for patients with less barriers to care.
Resource (Conference Presentation) updated 09/14/2023
Through creative innovation, multiple approaches have been employed to assist patients with medication adherence. This presentation will look at the introduction of a clinical pharmacist in an urban, Ryan White-funded clinic, the impact on medication adherence, and the viral suppression and demographic trends observed over four years.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will review updated data and discuss implementation challenges, facilitators, and best practices for routine screening/linkage in an emergency department with urban and rural challenges. Preliminary data from the initial two months (with more than 2,000 patients screened) include .7% HIV (including three acute infections), 7% Hepatitis C (HCV) and 5.2% syphilis.
Resource (Conference Presentation) updated 09/14/2023
Among people with HIV who also inject drugs, an estimated 80 to 90 percent are coinfected with Hepatitis C (HCV.) This panel will provide updates on screening and referral activities and demonstrate how community and city partners are overcoming barriers to HCV care among PWID.
Resource (Conference Presentation) updated 09/14/2023